Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations

PP Desai, AA Date, VB Patravale - Drug Discovery Today: Technologies, 2012 - Elsevier
Oral delivery of drugs with poor aqueous solubility and poor enzymatic and/or metabolic
stability is very challenging. However, the advent of nanotechnology has revolutionized the …
被引用次数：249 相关文章

[引用][C] Overcoming poor oral bioavailability using nanoparticle formulations-opportunities and limitations.

Drug Discovery today. Technologies, 2012 - europepmc.org
Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and
limitations. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

[引用][C] Overcoming Poor Oral Bioavailability using Nanoparticle Formulations-Opportunities and Limitations

PP Desai, AA Date… - Drug Discovery …, 2012 - researchworks.creighton.edu

Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations

PP Desai, AA Date, VB Patravale - Drug Discovery Today: Technologies, 2012 - infona.pl
Oral delivery of drugs with poor aqueous solubility and poor enzymatic and/or metabolic
stability is very challenging. However, the advent of nanotechnology has revolutionized the …

Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations

PP Desai, AA Date, VB Patravale - Drug Discovery Today: Technologies, 2012 - infona.pl
Oral delivery of drugs with poor aqueous solubility and poor enzymatic and/or metabolic
stability is very challenging. However, the advent of nanotechnology has revolutionized the …